Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/23/2010CA2765750A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010CA2765706A1 Methods and compositions for increasing trichogenic potency of dermal cells
12/23/2010CA2765700A1 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
12/23/2010CA2765577A1 Modulation of systemic exposure to rifaximin
12/23/2010CA2765541A1 Nanodispersion of a drug and process for its preparation
12/23/2010CA2765534A1 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010CA2765525A1 Compounds which selectively modulate the cb2 receptor
12/23/2010CA2765522A1 Solid pharmaceutical composition of edoxaban having improved solubility
12/23/2010CA2765509A1 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
12/23/2010CA2765466A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010CA2765446A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/23/2010CA2765415A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
12/23/2010CA2765413A1 Dosage forms of apixaban
12/23/2010CA2765408A1 New crystalline form of pemirolast
12/23/2010CA2765396A1 Compositions and methods for modulation of smn2 splicing in a subject
12/23/2010CA2765380A1 Connection device for a submersible connector
12/23/2010CA2765364A1 Influenza vaccine, composition, and methods of use
12/23/2010CA2765239A1 Pyrazinooxazepine derivatives
12/23/2010CA2765130A1 Anthelmintic agents and their use
12/23/2010CA2765015A1 Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010CA2764832A1 Lipid formulated dsrna targeting the pcsk9 gene
12/23/2010CA2764830A1 Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
12/23/2010CA2764542A1 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010CA2764438A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
12/23/2010CA2764401A1 Ectoparasiticidal formulations comprising spinetoram and methods of use thereof
12/23/2010CA2764187A1 Stable nanoparticulate drug suspension
12/23/2010CA2764177A1 Inhibitors of influenza viruses replication
12/23/2010CA2764124A1 Substituted isoquinoline derivative
12/23/2010CA2764013A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010CA2763778A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010CA2763730A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010CA2763720A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010CA2763551A1 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
12/23/2010CA2762458A1 New therapeutical uses of inecalcitol
12/23/2010CA2762304A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2264187A1 Method for diagnosing non-small cell lung cancers
12/22/2010EP2264179A1 Aminosugar compound and process for production thereof
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264171A1 Anti-myosine Va siRNA and skin depigmentation
12/22/2010EP2264170A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
12/22/2010EP2264169A1 Modified siNA
12/22/2010EP2264167A1 Double-stranded lipid-modified rna having high rna interference effect
12/22/2010EP2264046A1 Artificial CpG single-stranded oligodeoxynucleotide and antiviral use thereof
12/22/2010EP2264043A1 Heterobifunctional pan-selectin inhibitors
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/22/2010EP2264036A1 Amino-imidazolones for the inhibition of beta-secretase
12/22/2010EP2264035A1 Glycine B antagonists
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264033A1 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264031A2 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2264024A1 Process for the preparation of enantiomerically enriched proton pump inhibitors
12/22/2010EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
12/22/2010EP2264017A1 Heterocyclic derivative and use thereof
12/22/2010EP2264015A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
12/22/2010EP2264014A1 Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2263998A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
12/22/2010EP2263751A1 Isoxazole compound for the treatment of cancer
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263695A2 Method and preparation for treating depressions
12/22/2010EP2263694A1 Antitumor agent comprising the histone deacetylase inhibitor FK228 and a topoisomerase II inhibitor
12/22/2010EP2263680A1 Compressed pharmaceutical compositions comprising PEG and electrolytes
12/22/2010EP2263679A2 RNAi probes targeting cancer-related proteins
12/22/2010EP2263678A2 Cladribine regimen for treating Multiple Sclerosis
12/22/2010EP2263677A1 New therapeutical uses of inecalcitol
12/22/2010EP2263676A1 Anti-Hepatitis C composition and method for preparing drug for inhibiting Hepatitis C viruses or treating Hepatitis C
12/22/2010EP2263675A2 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/22/2010EP2263674A1 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
12/22/2010EP2263673A1 Opioid formulations having extended controlled release
12/22/2010EP2263672A1 Novel pharmaceutically acceptable salts of 4-(1H-imidazol-4-ylmethyl)pyridine and their therapeutical uses
12/22/2010EP2263671A1 Amide derivative-containing pharmaceutical composition
12/22/2010EP2263670A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2263667A2 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
12/22/2010EP2263666A1 Agent and food for prevention/amelioration of functional gastrointestinal disorders
12/22/2010EP2263665A1 New compositions for treating CMT and related disorders
12/22/2010EP2263664A1 Opioid receptors stimulating compounds (thymoquinone, Nigella sativa) and food allergy
12/22/2010EP2263663A1 Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
12/22/2010EP2263660A2 Orally disintegrable tablets
12/22/2010EP2263659A1 Contraceptive comprising folic acid
12/22/2010EP2263658A1 Controlled release hydrocodone formulations
12/22/2010EP2263657A1 Controlled release lamotrigine formulations
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2263654A1 Compositions and methods to improve the oral absorption of antimicrobial agents
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
12/22/2010EP2263651A2 Low viscosity liquid dosage forms
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
12/22/2010EP2263649A1 Pharmacological adjuvants based on coordination compounds of d-metals
12/22/2010EP2263648A1 Ophthalmic composition
12/22/2010EP2263596A1 Dispensing apparatus and cartridge
12/22/2010EP2263582A2 Spine distraction implant
12/22/2010EP2263581A2 Spine distraction implant
1 ... 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 ... 7860